While an elevation in PHB2 protein levels in peripheral blood mononuclear cells (PBMC) has been documented [36], it is disappointing that we did not observe a significant alteration at the gene level for PHB2 in MS compared with control subjects. This evidence concerns the gene PHB2 and myeloid sarcoma.